Results 1 to 10 of about 10,129 (256)

Synthesis of Acridine-based DNA Bis-intercalating Agents [PDF]

open access: yesMolecules, 2001
Methods for the synthesis of N1, N8-bis(9-acridinyl)-N4-(4-hydroxybenzyl)-spermidine and N1, N7-(hydroxybenzyl)-bis-(3-aminopropyl)amine were investigated.
P. Mack   +2 more
doaj   +2 more sources

Tumour initiated purinergic signalling promotes cardiomyocyte RBFOX1 degradation and cardiotoxicity from DNA damaging anticancer agents [PDF]

open access: yesNature Communications
It is well established tumour cells secrete signalling factors affecting distant normal tissues. What remains unresolved is whether these factors initiate a signalling cascade rendering terminally differentiated cardiomyocytes susceptible to apoptosis, a
Saymon Tejay   +13 more
doaj   +2 more sources

Green clay engineering via dimethyl sulfoxide, dimethylformamide, and urea-assisted exfoliation of serpentinite for efficient azithromycin adsorption as emerging pharmaceutical pollutant [PDF]

open access: yesScientific Reports
Azithromycin (AZT), a persistent macrolide antibiotic, is an emerging environmental contaminant due to its high aqueous stability and role in antimicrobial resistance. In this study, natural serpentinite was chemically exfoliated using dimethyl sulfoxide
Amira S. Diab   +4 more
doaj   +2 more sources

Evaluation of Docking Machine Learning and Molecular Dynamics Methodologies for DNA-Ligand Systems

open access: yesPharmaceuticals, 2022
DNA is a molecular target for the treatment of several diseases, including cancer, but there are few docking methodologies exploring the interactions between nucleic acids with DNA intercalating agents.
Tiago Alves de Oliveira   +6 more
doaj   +1 more source

Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2022
This research presents the design and synthesis of a novel series of phthalazine derivatives as Topo II inhibitors, DNA intercalators, and cytotoxic agents.
Mohamed M. Khalifa   +6 more
doaj   +1 more source

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV

open access: yesPharmaceuticals, 2023
Increases in antibiotic usage and antimicrobial resistance occurrence have caused a dramatic reduction in the effectiveness of many frontline antimicrobial treatments.
Scott Grossman   +2 more
doaj   +1 more source

Agarose gel electrophoresis to assess PCR product yield: comparison with spectrophotometry, fluorometry and qPCR

open access: yesBioTechniques, 2022
Agarose gel electrophoresis is a relatively easy to use method, commonly applied to evaluate PCR reaction success. Intercalating agents or dyes are used to visualize the amplified fragments. However, it is uncertain to what extent the brightness of bands
Patrick Wittmeier, Susanne Hummel
doaj   +1 more source

Payload diversification: a key step in the development of antibody–drug conjugates

open access: yesJournal of Hematology & Oncology, 2023
Antibody–drug conjugates (ADCs) is a fast moving class of targeted biotherapeutics that currently combines the selectivity of monoclonal antibodies with the potency of a payload consisting of cytotoxic agents. For many years microtubule targeting and DNA-
Louise Conilh   +3 more
doaj   +1 more source

Molecular modelling assisted design of napthalimide-dihydropyrimidinone conjugates as potential cytotoxic agents

open access: yesJournal of Saudi Chemical Society, 2021
A molecular modelling assisted design of napthalimide-dihydropyrimidinone conjugates as potential cytotoxic agents based on a lead molecule (elinafide) is described.
M. Shaheer Malik   +12 more
doaj   +1 more source

2,4-Dichlorophenoxyacetic Thiosemicarbazides as a New Class of Compounds against Stomach Cancer Potentially Intercalating with DNA

open access: yesBiomolecules, 2020
Thiosemicarbazide is a useful structural moiety that has the biological potential. Optimization of this structure can result in groundbreaking discovery of a new class of therapeutic agents.
Monika Pitucha   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy